Showing 2941-2950 of 4166 results for "".
- Gemini Therapeutics Initiates GEM103 Phase 2a Study as an Add-On to Anti-VEGF Therapy for the Treatment of Wet AMD Patients at Risk for Progressive Vision Loss Due to Macular Atrophyhttps://modernod.com/news/gemini-therapeutics-initiates-gem103-phase-2a-study-as-an-add-on-to-anti-vegf-therapy-for-the-treatment-of-wet-amd-patients-at-risk-for-progressive-vision-loss-due-to-macular-atrophy/2478815/Gemini Therapeutics announced the commencement of a phase 2a trial advancing GEM103 as a potential add-on therapy for patients suffering from wet AMD who have, or may be at risk for, macular atrophy (MA) but require ongoing anti-vascular endothelial growth factor (anti-VEGF) treatment. Topline da
- Aldeyra Therapeutics Announces Planned Pivotal Clinical Trial for RP Drug Candidatehttps://modernod.com/news/aldeyra-therapeutics-announces-planned-pivotal-clinical-trial-for-retinitis-pigmentosa-drug-candidate/2482247/Aldeyra Therapeutics hosted the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City on April 25 where it presented recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the treatment of retinitis pigmentosa.
- Zeiss Expands its Clinical Workflows and Digital Portfolio at AAO 2023https://modernod.com/news/zeiss-expand-its-clinical-workflows-and-digital-portfolio-at-aao-2023/2481915/Zeiss Medical Technology will showcase digital enhancements to the cataract, corneal refractive, and retina workflows at the American Academy of Ophthalmology (AAO) conference from Nov. 4-6, 2023, in San Francisco. As part of the Zeiss Medical Ecosystem, these innovations offer new digital tools
- Roche Stops Clinical Development of Oral Drug Candidate for Diabetic Retinopathyhttps://modernod.com/news/roche-stops-clinical-development-of-oral-drug-candidate-for-diabetic-retinopathy/2481902/Roche has decided to stop development of vicasinabin, an oral drug cadidate being evaluated for non-proliferative diabetic retinopathy, after completing phase 2 trials, according to a FiercePharma
- Rayner Completes First Implantations of IOLs in Clinical Trials in China and the UShttps://modernod.com/news/rayner-achieves-milestone-implantations-in-clinical-trials-in-china-and-the-us/2481774/Rayner has announced the completion of the first implantations in two pivotal market access studies in the US and China. Rayner's RayOne EMV Toric IOL received investigational device exemption (IDE) approval from the FDA in June. The first study implantation took place at
- Aurion Biotech to Present Clinical Trial Results at the 2023 ASCRS Annual Meetinghttps://modernod.com/news/aurion-biotech-to-present-clinical-trial-results-at-the-2023-ascrs-annual-meeting/2481586/Aurion Biotech announced several presentations during the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held May 5-8, 2023 in San Diego, California. At Eyecelerator and ASCRS 2023, data will be presented from the comp
- TearRestore Announces Positive Clinical Trial Results for Patients with Dry Eye Diseasehttps://modernod.com/news/tearrestore-announces-positive-clinical-trial-results-for-patients-with-dry-eye-disease/2481456/TearRestore announced positive toptine results of a study conducted by the University of Colorado titled, “The Effect of Warm Compress Therapy on Dry Eye Disease,” using the TearR
- TearSolutions Announces Results From First-In-Human Clinical Trial Published in Corneahttps://modernod.com/news/tearsolutions-announces-results-from-first-in-human-clinical-trial-published-in-cornea/2481129/TearSolutions announced that the
- Sight Sciences Announces TearCare Clinical Data Published in Corneahttps://modernod.com/news/sight-sciences-announces-tearcare-clinical-data-published-in-cornea/2480366/Sight Sciences announced publication in the journal
- Modernizing Medicine Releases Enhanced Ophthalmic Image Management to Improve Clinical Workflowhttps://modernod.com/news/modernizing-medicine-releases-enhanced-ophthalmic-image-management-to-improve-clinical-workflow/2479198/Modernizing Medicine announced it has released the latest version of ophthalmic Image Management aimed at helping ophthalmologists save time and deliver efficiency associated with diagnostic imaging workflows. Many ophthalmologists benefit from having an all-in-one solution that bridges da